U.S. Software Stock News

NYSE:ABBV
NYSE:ABBVBiotechs

Is AbbVie (ABBV) Still Worth Considering After Recent Share Price Pullback?

Investors may be wondering if AbbVie at around US$202 a share still offers value, or if most of the opportunity has already played out. The stock has recently seen mixed returns, with a 4.1% decline over the last 7 days, a 1.8% decline over 30 days, and an 11.6% decline year to date. Over 1 year and 5 years, the returns stand at 12.8% and 109.7% respectively. Recent headlines have focused on AbbVie's position in the large-cap pharmaceuticals space and how investors are weighing its long term...
NasdaqGS:DKNG
NasdaqGS:DKNGHospitality

Is It Time To Revisit DraftKings (DKNG) After Recent Share Price Rebound

If you are trying to work out whether DraftKings stock looks attractively priced or too expensive at today’s levels, you will want more than just the latest share price in front of you. The stock recently closed at US$25.22, with returns of 8.1% over 7 days and 9.9% over 30 days, while year to date and 1 year returns of negative 29.3% and negative 28.7% show a very different picture over a longer window. Recent headlines around DraftKings have largely focused on the broader US sports betting...
NYSE:SEI
NYSE:SEIEnergy Services

Should SEI’s 600 MW Hyperscaler Deal and $1.3 Billion Notes Shape Solaris Energy Infrastructure Investors’ Plans?

In early May 2026, Solaris Energy Infrastructure’s subsidiary completed the pricing of US$1.30 billion of 6.375% senior unsecured notes due 2031, intended to refinance existing borrowings, cover fees and expenses, and support general corporate purposes including growth capital expenditures. This financing followed a strong first quarter 2026, when Solaris reported sharply higher revenue and net income and secured a new 10-year agreement to supply over 600 MW of power capacity and...
NasdaqGS:BYND
NasdaqGS:BYNDFood

Assessing Beyond Meat (BYND) Valuation After Narrowing Q1 Losses And Softer Sales

Q1 results and new shelf registration Beyond Meat (BYND) has drawn fresh attention after reporting first quarter 2026 results, which showed a reduced net loss alongside lower sales. This was followed shortly by a US$10.4 million shelf registration tied to an employee stock ownership plan. See our latest analysis for Beyond Meat. The stock has moved sharply around the Q1 update and ESOP shelf filing, with a 30-day share price return of 53.93% contrasting with a 1-year total shareholder return...
NYSE:NU
NYSE:NUBanks

Is Nu Holdings (NU) Still Attractive After Recent Pullback And Strong Three Year Run?

Wondering if Nu Holdings is still good value at around US$14.26, or if the easy gains are already behind it? This overview sets you up to judge the stock price with a clear, structured lens. The stock has returned 11.4% over the last year and a very large 3 year gain, even as the year to date move sits at a 16.2% decline, which can change how the market views both its growth potential and risk. Recent headlines have focused on Nu Holdings as a large listed Latin American digital bank, often...
NYSE:ZTS
NYSE:ZTSPharmaceuticals

Zoetis Resets Outlook As U.S. Pet Weakness Pressures Valuation And Growth

Zoetis (NYSE:ZTS) has cut its full year guidance after a sharp downturn in its U.S. companion animal business. Management points to higher price sensitivity among pet owners, fewer veterinary visits, and more generic competition as key pressures. The company is refocusing on integrated solutions, tighter cost controls, and operational efficiency as part of a broad reset. For investors, the reset lands on top of a steep share price pullback. Zoetis now trades at $87.31, with the stock down...
NasdaqGS:KRYS
NasdaqGS:KRYSBiotechs

Is It Too Late To Consider Krystal Biotech (KRYS) After Its Strong Share Price Run?

For investors wondering if Krystal Biotech at around US$296.70 is still offering value or if the easy gains are behind it, this article walks through what the current price may be implying. The stock has shown strong share price moves, with returns of 13.1% over 7 days, 12.4% over 30 days, 20.2% year to date, 116.3% over the last year, 228.5% over 3 years, and 374.4% over 5 years. These price moves sit against a backdrop of ongoing attention on Krystal Biotech's position in the...
NasdaqGS:RARE
NasdaqGS:RAREBiotechs

Ultragenyx Pharmaceutical (RARE) Is Up 5.8% After Reaffirming 2026 Outlook Despite Wider Losses – What's Changed

Ultragenyx Pharmaceutical Inc. reported past first-quarter 2026 results with revenue of US$136 million, a wider net loss of US$185 million, and reaffirmed its 2026 revenue guidance of US$730 million to US$760 million while remaining on a stated path toward profitability in 2027. Management also highlighted potential 2026 approvals for two gene therapies and key late-stage data for its Angelman syndrome program, underscoring how clinical and regulatory milestones are central to its...
NYSE:AXP
NYSE:AXPConsumer Finance

American Express Satisfaction Streak Supports Premium Brand And Valuation Story

American Express was ranked #1 in U.S. Credit Card Customer Satisfaction in the 2025 JD Power Study. This is the sixth consecutive year the company has taken the top spot. The study highlights especially strong satisfaction for premium and fee-based cardholders. The recognition comes as American Express refreshes benefits on its Gold Card product. For investors watching NYSE:AXP, this recognition adds another data point to the company’s premium brand story. The stock is trading at $318.69,...
NasdaqGS:ROCK
NasdaqGS:ROCKBuilding

Gibraltar Industries (ROCK) Margin Compression And Q1 EPS Loss Test Bullish Growth Narrative

Gibraltar Industries (ROCK) opened Q1 2026 with total revenue of US$356.3 million and a basic EPS loss of US$0.40, setting a cautious tone around the latest numbers. The company has seen quarterly revenue move from US$246.4 million and EPS of US$0.76 in Q1 2025 through a series of US$309.5 million to US$310.9 million quarters with EPS between US$0.99 and US$1.12, before landing at US$268.7 million and EPS of US$0.40 in Q4 2025. This gives investors a clear look at how the top line has...
NYSE:MTG
NYSE:MTGDiversified Financial

How Investors Are Reacting To MGIC Investment (MTG) Q1 Revenue Dip With Stable EPS

MGIC Investment Corporation recently reported its first-quarter 2026 results, with revenue of US$297.08 million and net income of US$165.3 million, both lower than the same period a year earlier. Despite the revenue and profit declines, MGIC’s basic and diluted earnings per share from continuing operations held around US$0.76, indicating stable per-share profitability even as overall earnings softened. Now we’ll examine how this combination of lower revenue but steady earnings per share...
NYSE:ALB
NYSE:ALBChemicals

The Bull Case For Albemarle (ALB) Could Change Following Q1 Earnings Beat And Balance Sheet Gains – Learn Why

Albemarle Corporation recently reported first-quarter 2026 results, with sales rising to US$1,428.73 million and net income increasing to US$319.09 million, alongside basic earnings per share from continuing operations of US$2.35 and a quarterly dividend of US$0.405 per share payable on July 1, 2026. The quarter’s outcome was underpinned by much stronger pricing and volume in the Energy Storage and Specialties segments, together with debt reduction funded by divestitures that strengthened...
NasdaqCM:SGML
NasdaqCM:SGMLMetals and Mining

Is It Too Late To Consider Sigma Lithium (SGML) After Its Strong 1 Year Rally?

Wondering if Sigma Lithium's current share price reflects its true worth, or if the recent excitement has run ahead of the fundamentals? The stock last closed at US$23.65, with returns of 7.2% over 7 days, 61.7% over 30 days, 66.4% year to date, 218.7% over 1 year and 401.5% over 5 years, while the 3 year return stands at a loss of 40.0%. Recent coverage has focused on Sigma Lithium as a lithium producer, with investors watching how sentiment around the sector and the company's development...
NYSE:ES
NYSE:ESElectric Utilities

Eversource Energy (ES) Earnings Surge And Margin Expansion Test Long Term Bearish Narratives

Eversource Energy (ES) opened 2026 with Q1 revenue of about US$4.5 billion and basic EPS of US$1.61, setting the stage against a year of sharply higher trailing earnings and wider margins. Over the last six reported quarters, quarterly revenue has ranged from US$2.8 billion to US$4.5 billion while basic EPS has moved between roughly US$0.20 and US$1.61, and on a trailing twelve month basis EPS reached US$4.69 alongside revenue of about US$13.9 billion. With trailing net margin sitting above...
NYSE:SAH
NYSE:SAHSpecialty Retail

Will Sonic Automotive's (SAH) Dividend Hike and ESOP Share Shelf Change Its Capital Allocation Narrative

In late April 2026, Sonic Automotive reported first-quarter 2026 results showing revenue of US$3,688.5 million, net income of US$60.8 million, and diluted EPS of US$1.79, while also announcing a higher quarterly dividend of US$0.4100 per share and continued progress on a long-running share repurchase program. Just days later, Sonic Automotive filed a US$151.18 million shelf registration for 2,000,000 Class A shares tied to its ESOP, underscoring how capital returns and employee ownership are...
NYSE:NABL
NYSE:NABLSoftware

N Able (NABL) Q1 Revenue Growth Tests Profitability Turnaround Narratives

N-able (NABL) has opened 2026 with Q1 revenue of US$133.7 million and a basic EPS loss of US$0.00, alongside net income excluding extraordinary items of a US$0.6 million loss, setting a mixed tone for the latest results. Over recent quarters the company has seen revenue move from US$118.2 million in Q1 2025 to US$133.7 million in Q1 2026, while basic EPS has shifted between a profit of US$0.01 in Q3 2025 and a larger loss of US$0.04 in Q4 2025 before this latest small loss per share. For...
NasdaqGS:EQIX
NasdaqGS:EQIXSpecialized REITs

Stronger Q1 Results And Higher Guidance Could Be A Game Changer For Equinix (EQIX)

Equinix reported past first-quarter 2026 results with net income of US$415 million, up from US$343 million a year earlier, alongside higher earnings per share and a maintained quarterly dividend of US$5.16 per share. The company also slightly raised its full-year 2026 revenue and dividend guidance and issued new Canadian dollar senior notes, signaling continued investment in global digital infrastructure capacity. We’ll now examine how Equinix’s upgraded 2026 outlook and recurring revenue...
NasdaqGS:COLB
NasdaqGS:COLBBanks

Do Columbia Banking System’s Integration Costs and Buybacks Reveal a New Strategic Balance for COLB?

In the past quarter, Columbia Banking System reported first-quarter 2026 earnings of US$0.66 per diluted share, below the US$0.69 analyst estimate, as higher non-interest expenses tied to integrating its August 2025 Pacific Premier acquisition weighed on results. Despite the earnings miss, net income rose to US$192.0 million from US$87.0 million a year earlier, helped by loan growth, higher yields, the Pacific Premier deal, and a US$700.0 million share repurchase program under which US$200.0...
NYSE:MS
NYSE:MSCapital Markets

The Bull Case For Morgan Stanley (MS) Could Change Following Its Broad E*Trade Crypto Rollout Expansion

Morgan Stanley has recently begun rolling out cryptocurrency trading on its E*Trade platform in a pilot for 8.6 million clients, initially supporting bitcoin, ethereum, and solana with transaction fees of 0.50% and planned integration with its new crypto ETFs and tokenized equity services. This marks a material expansion of Morgan Stanley’s digital asset infrastructure, positioning its mainstream brokerage clients closer to the emerging market for event contracts, tokenized securities, and...
NasdaqGS:PCVX
NasdaqGS:PCVXBiotechs

Vaxcyte (PCVX) Is Down 10.1% After Wider Q1 Loss But Completing Key VAX-31 Phase 3 Enrollment

Vaxcyte recently reported first-quarter 2026 results showing a wider net loss of US$320.62 million, with basic and diluted loss per share from continuing operations of US$2.30, compared with a loss of US$140.72 million and US$1.04 per share a year earlier. Around the same time, the company completed enrollment in its adult Phase 3 OPUS-1, OPUS-2 and OPUS-3 trials for VAX-31 and set plans to start a Phase 1 adult study for its VAX-A1 Group A Strep vaccine candidate, signaling meaningful...
NYSE:Q
NYSE:QSemiconductor

Is It Too Late To Consider Qnity Electronics (Q) After A 69% Year To Date Surge?

If you are wondering whether Qnity Electronics at around US$143.59 is richly priced or still offers value, this breakdown outlines what the current share price might be implying. The stock has returned 2.1% over the last 7 days, 20.7% over the past month, and 69.0% year to date, which has put valuation squarely on investors' radar. Recent coverage has focused on Qnity Electronics' position within the semiconductor sector and how investors are reassessing companies tied to data infrastructure...
NYSE:TKO
NYSE:TKOEntertainment

TKO Group Holdings (TKO) Margin Improvement Tests Bullish High Quality Earnings Narrative

TKO Group Holdings (TKO) opened 2026 with Q1 revenue of about US$1.6b and basic EPS of US$1.16, alongside trailing 12 month EPS of US$2.84 on revenue of roughly US$5.1b and net income of US$226.35m, setting a clear marker for how the business is currently earning. Over recent quarters, revenue has moved from US$927.92m in Q4 2024 to US$1.27b in Q1 2025 and then to US$1.60b in Q1 2026. Quarterly basic EPS has ranged from US$0.38 in Q4 2024 to US$0.72 in Q1 2025 and US$1.16 in Q1 2026, giving...
NYSE:YSS
NYSE:YSSAerospace & Defense

Is York Space Systems (YSS) Offering Value After Recent 30 Day Share Price Jump

If you are wondering whether York Space Systems is fairly priced or offering an opportunity at current levels, the next sections break down what the numbers suggest about value. The stock recently closed at US$33.38, with returns of 0.7% over the past week, 21.1% over the last 30 days, and a small year to date decline of 0.7%. This may catch the eye of investors watching for a turning point in sentiment. Recent attention around York Space Systems has focused on its position in the space and...
NYSE:BVN
NYSE:BVNMetals and Mining

Is Surging Q1 Results And New Board Leadership Altering The Investment Case For Buenaventura (BVN)?

Compañía de Minas Buenaventura S.A.A. recently reported first-quarter 2026 results, with revenue of US$624.56 million and net income of US$335.39 million, and its board met on April 29, 2026, to consider appointing Roque Eduardo Benavides Ganoza as Chairman and Shehzad Bharmal as Lead Director. The near doubling of quarterly revenue and earnings compared with a year earlier, alongside potential leadership changes, highlights both operational momentum and evolving governance at the Peruvian...